Targeting CXCR4-B2AR Heteromers in Cancer: Assays to Interrogate Heteromer Function

Time: 11:00 am
day: Pre Conference Focus Day


  • Introduce the technology used to identify GPCR heteromers to generate a database of interacting partners, as well as the selection of our lead targets in cancer
  • Share our strategy for in situ validation of CXCR4-B2AR targets
  • Discussion of in vitro validation of CXCR4-B2AR heteromer function by utilizing a variety of assay systems